Medical News Powered by SEO Press Releases™ Press Release Distribution
552 views
printerPrint  | 

     
     
Boston, MA, April 18, 2011 — Amniotic fluid stem cells are making international headlines as an April 13 article in Britain’s leading newspaper The Daily Telegraph, reports an exciting scientific breakthrough at the University of Edinburgh. Scientists there report growing a tiny kidney – created in a laboratory using human amniotic fluid and animal fetal cells. According to the article, this kidney may be able to grow into a full-size organ that might be transplanted into a human. What this means, the article states, is that within ten years patients may no longer have to wait for a risky and expensive organ transplant or live on a dialysis machine but instead receive their own replacement organs.

Physiologist Jamie Davies, a professor of experimental anatomy at Edinburgh University, said in the article: ”It sounds a bit science fiction-like but it’s not. ‘The idea is to start with human stem cells and end up with a functioning organ.”

”We have made pretty good progress with that. We can make something that has the complexity of a normal, fetal kidney.”

Professor Davies said the technology could be ready for use on humans in around 10 years. He added: ”Freezing a few cells is cost-effective compared with the cost of keeping someone on dialysis for years.

The breakthrough will be officially unveiled at Edinburgh’s Science Festival this month.

The Daily Telegraph story underscores the importance of companies like Biocell Center, the leader in amniotic fluid preservation. “Amniotic stem cells represent an important hope for the future of stem cell therapy,” noted Professor Giuseppe Simoni, Biocell Center’ Scientific Director and Professor of Human Genetics at the University of Milan in a recent interview. “Biocell Center has been studying cells from amniotic fluid for years and is the leading international company offering the service of amniotic fluid stem cell cryopreservation to women during their pregnancy.”


author-feeds

Other press releases from GCI Health


Contact Information

Laurie Fullerton
Title: Public Relations Director
Biocell Center Corporation
200 Boston Avenue
Boston, Medford, MA 02155
Phone: 781- 391-2040
Alt. Phone: 1-866-246-2720
Fax: 1-781-395-0602
Email: laurie.fullerton@biocellcenter.com
Visit Website

Additional Contact

Andrea Fassacesia
Title: Senior Account Executive
GCI Health
200 Fifth Avenue
New York 10010
Phone: (212) 798-9942
Email: Andrea.Fassacesia@gcihealth.com
Visit Website


Contact Information

Laurie Fullerton
Title: Public Relations Director
Biocell Center Corporation
200 Boston Avenue
Boston, Medford, MA 02155
Phone: 781- 391-2040
Alt. Phone: 1-866-246-2720
Fax: 1-781-395-0602
Email: laurie.fullerton@biocellcenter.com
Visit Website

Additional Contact

Andrea Fassacesia
Title: Senior Account Executive
GCI Health
200 Fifth Avenue
New York 10010
Phone: (212) 798-9942
Email: Andrea.Fassacesia@gcihealth.com
Visit Website

Blogs & Social Networks

Media Center

No video clips available.

Simpler Computing - Wordpress Plugins - Help Desk Plugin